Improving the School Vaccination Experience: What CARDs Are You Going to Play?

June 23, 2021 updated by: Anna Taddio, University of Toronto

Playing CARDs to Improve the Vaccination Experience at School: a Cluster Randomized Controlled Trial

Vaccination hesitancy is identified as a threat to global health by the World Health Organization (WHO). For adolescents undergoing vaccination at school, prior studies demonstrate that concerns about pain and/or fear of needles contribute to negative experiences with vaccination and non-compliance with vaccination. The investigators developed an intervention that addresses vaccination hesitancy. In this study, investigators will evaluate the effectiveness of this intervention in a randomized controlled trial.

Study Overview

Detailed Description

Vaccination hesitancy is identified by the World Health Organization (WHO) as one of ten threats to global health. The WHO's 3C model of vaccination hesitancy identifies 3 domains of vaccine hesitancy: 1) Confidence (trust in health care providers), 2) Complacency (perceived importance of vaccine-preventable disease) and 3) Convenience (improving clinic processes). The investigators developed a multifaceted knowledge translation intervention that addresses vaccination hesitancy in school-based vaccinations. The intervention is called The CARD(TM) System (C-Comfort, A-Ask, R-Relax, D-Distract). CARD is a framework for delivering vaccinations that is student-centred and promotes coping. CARD integrates evidence-based interventions related to planning and execution of school vaccination clinics to directly tackle all 3 domains of vaccination hesitancy. It tackles Confidence by improving pain/fear management (it teaches students and public health staff how to reduce student symptoms which improves the vaccination experience and improves student trust in health care providers). It tackles Complacency by educating students about what vaccines are, why they are needed, community immunity, as well as the specific diseases they are being protected against. It tackles Convenience by improving school-based clinic processes by integrating student preferences (e.g., privacy, having a support person present).

In this randomized controlled trial, the investigators will evaluate the impact of CARD (vs. usual care) on student important outcomes and process outcomes.

Study Type

Interventional

Enrollment (Actual)

1919

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Guelph, Ontario, Canada, L9W 1K3
        • Wellington Dufferin Guelph Public Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • grade 7 students eligible for vaccination at school
  • public health staff working in the school vaccination program

Exclusion Criteria:

  • unable to understand and read English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CARD (multi-faceted knowledge translation intervention)
CARD will be integrated into the school vaccination program. This includes pre-vaccination day preparation (e.g., planning of clinic spaces, student and school staff education about CARD) and vaccination day activities (e.g., clinic set-up, processes for triaging students, implementing pain/fear/fainting mitigation interventions from CARD during vaccination)
The intervention consists of education of relevant stakeholders of best practices and integration of best practices into the vaccination delivery program
Other Names:
  • CARD
No Intervention: Control (standard/usual care)
There are no specific procedures being undertaken to plan or execute clinics. Usual practices will be instituted (i.e., no education specific to CARD, nor clinic set-up or execution to incorporate interventions for pain, fear or fainting)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Student fear
Time Frame: within 5 minutes after vaccination
student self-reported fear during vaccination, rated on a 0-10 scale
within 5 minutes after vaccination

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Student pain
Time Frame: within 5 minutes after vaccination
student self-reported pain during vaccination, rated on a 0-10 scale
within 5 minutes after vaccination
Student fainting
Time Frame: within 1 hour after vaccination
student fainting during vaccination, yes/no, as assessed by immunizer
within 1 hour after vaccination
Uptake of vaccination
Time Frame: by end of school year
proportion of students vaccinated (overall and for each vaccine)
by end of school year
Student dizziness
Time Frame: within 5 minutes of vaccination
student self-reported dizziness during vaccination, rated on a 0-10 scale
within 5 minutes of vaccination
Student post-immunization stress-related responses
Time Frame: within 1 hour after vaccination
student post-immunization stress-related responses, yes/no, as assessed by immunizer using the WHO immunization Stress Responses Criteria
within 1 hour after vaccination
Utilization of coping strategies
Time Frame: within 5 minutes after vaccination
use of individual coping strategies during vaccination (distraction, topical anesthetic, privacy, support person, deep breathing, muscle tension), yes/no, as assessed by immunizer using Documentation Checklist
within 5 minutes after vaccination
Implementation success of CARD
Time Frame: within 3 months of vaccination clinics
perceptions of implementation success of CARD program delivery as reported by CARD implementers (primary targets) using the CARD Global Impression Checklist, individual questions (5-point likert scale, higher number represents better outcome). This information will be supplemented with information from focus groups with implementers and study notes
within 3 months of vaccination clinics
Compliance with CARD
Time Frame: within 3 months of vaccination clinics
percent compliance with CARD implementation as assessed by implementers using a CARD compliance checklist. This information will be supplemented with information from focus groups with implementers and study notes
within 3 months of vaccination clinics
Knowledge of effective coping strategies
Time Frame: within 3 months after vaccination clinics
knowledge of effective coping strategies, as assessed using a 10-point investigator-developed knowledge test, administered to implementers
within 3 months after vaccination clinics
Perceptions about pain and fear
Time Frame: within 3 months of vaccination clinics
perceptions about pain and fear, as assessed using a 5-point likert scale (higher number represents better outcome) for implementers
within 3 months of vaccination clinics
Perceptions about vaccination program
Time Frame: within 3 months of vaccination clinics
perceptions about vaccination program, as assessed using the Vaccination Program Global Impresssion Checklist, individual questions (5-point likert scale, higher number represents better outcome) for implementers
within 3 months of vaccination clinics
Willingness to be vaccinated
Time Frame: within 5 minutes after vaccination
student self-reported willingness to be vaccinated, as assessed using a 5-point likert scale (higher number represents better outcome)
within 5 minutes after vaccination
Satisfaction with CARD
Time Frame: within 5 minutes after vaccination
student self-reported satisfaction with CARD, as assessed using Student Feedback Survey, individual questions (5-point likert scale, higher number indicates better outcome)
within 5 minutes after vaccination

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anna Taddio, PhD, University of Toronto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2019

Primary Completion (Actual)

November 20, 2019

Study Completion (Actual)

November 22, 2019

Study Registration Dates

First Submitted

May 25, 2019

First Submitted That Met QC Criteria

May 25, 2019

First Posted (Actual)

May 29, 2019

Study Record Updates

Last Update Posted (Actual)

June 29, 2021

Last Update Submitted That Met QC Criteria

June 23, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan to share IPD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe